WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003078422) NOVEL PYRIDONE DERIVATIVE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/078422    International Application No.:    PCT/JP2003/003115
Publication Date: 25.09.2003 International Filing Date: 14.03.2003
Chapter 2 Demand Filed:    15.10.2003    
IPC:
A61K 31/444 (2006.01), C07D 401/14 (2006.01)
Applicants: BANYU PHARMACEUTICAL CO., LTD. [JP/JP]; 2-3, Nihombashi Honcho 2-chome, Chuo-ku, Tokyo 103-8416 (JP) (For All Designated States Except US).
SATO, Nagaaki [JP/JP]; (JP) (For US Only).
NAGASE, Tsuyoshi [JP/JP]; (JP) (For US Only).
NAGAI, Keita [JP/JP]; (JP) (For US Only).
ANDO, Makoto [JP/JP]; (JP) (For US Only).
KANATANI, Akio [JP/JP]; (JP) (For US Only)
Inventors: SATO, Nagaaki; (JP).
NAGASE, Tsuyoshi; (JP).
NAGAI, Keita; (JP).
ANDO, Makoto; (JP).
KANATANI, Akio; (JP)
Common
Representative:
BANYU PHARMACEUTICAL CO., LTD.; 2-3, Nihombashi Honcho 2-chome, Chuo-ku, Tokyo 103-8416 (JP)
Priority Data:
2002-073120 15.03.2002 JP
Title (EN) NOVEL PYRIDONE DERIVATIVE
(FR) NOUVEAU DERIVE DE PYRIDONE
Abstract: front page image
(EN)A compound represented by the general formula (I): (I) (wherein R1 means hydrogen, halogeno, cyano, lower alkyl, lower haloalkyl, hydroxy, lower alkoxy, or aralkyloxy; R2 and R3 each independently means hydrogen, halogeno, or lower haloalkyl; and R4 and R5 each independently means hydrogen or halogeno) and the like. The compounds are useful as a therapeutic agent for various diseases in which NPY participates, e.g., overeating, obesity, and diabetes.
(FR)L'invention concerne un composé représenté par la formule générale (I), (dans laquelle R1 représente hydrogène, halogéno, cyano, alkyle inférieur, haloalkyle inférieur, hydroxy, alcoxy inférieur, ou aralkyloxy; R2 et R3 représentent chacun indépendamment hydrogène, halogéno, ou haloalkyle inférieur; et R4 et R5 représentent chacun indépendamment hydrogène ou halogéno), et analogue. Les composés sont d'utiles agents thérapeutiques contre diverses maladies dans lesquelles NPY participe, par exemple l'hyperphagie, l'obésité et les diabètes.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)